Holger Thiele
Holger Thiele
Impella support for cardiogenic shock and high-risk percutaneous coronary intervention: A single-center experience [0.03%]
心室辅助装置支持治疗心源性休克和高危经皮冠状动脉介入治疗的单中心经验
Mariana Brandão,Daniel Caeiro,Gustavo Pires-Morais et al.
Mariana Brandão et al.
Introduction and objectives: The use of mechanical circulatory support is increasing in cases of cardiogenic shock (CS) and high-risk percutaneous coronary intervention (HR-PCI). The Impella® is a percutaneous ventricula...
Immune cell subsets as a marker of development of heart failure: The application of bioinformatics tools [0.03%]
免疫细胞亚群作为心力衰竭发展的标志物：生物信息学工具的应用
Mónica Teresa Abreu,Rui Baptista,Henrique Girão
Mónica Teresa Abreu
Peripheral neutrophils and naive CD4 T cells predict the development of heart failure following acute myocardial infarction: A bioinformatic study [0.03%]
外周中性粒细胞和初始CD4 T细胞可预测急性心肌梗死后心力衰竭的发生：生物信息学研究
Congyi Yu,Wenjun Zhou
Congyi Yu
Introduction: Heart failure (HF) secondary to acute myocardial infarction (AMI) is still a worldwide problem with a high mortality rate. The current study aimed to explore early and reliable predictive biomarkers of HF fo...
Tiago Pereira-da-Silva
Tiago Pereira-da-Silva
A new biomarker that predicts ventricular arrhythmia in patients with ischemic dilated cardiomyopathy: Galectin-3 [0.03%]
一个新的生物标志物可以预测缺血性扩张型心肌病患者是否会发生室性心律失常：半乳糖凝集素-3
Onur Erdogan,Ekrem Karaayvaz,Tugba Erdogan et al.
Onur Erdogan et al.
Introduction: Ventricular arrhythmias are caused by scar tissue in patients with ischemic dilated cardiomyopathy. The gold standard imaging technique for detecting scar tissue is magnetic resonance imaging (MRI). However,...
Daniel Ferreira
Daniel Ferreira
Inês Fialho,Marco Beringuilho,Daniela Madeira et al.
Inês Fialho et al.
Introduction and objectives: The Internet is a fundamental aspect of health information. However, the absence of quality control encourages misinformation. We aim to assess the relevance and quality of acute myocardial in...
Reply to letter "Beta-blockers in acute coronary syndrome patients: The concept of 'gradient of benefit"' [0.03%]
回复信件“急性冠脉综合征患者中的β受体阻滞剂：获益‘梯度’的概念”
Jesús Velásquez-Rodríguez,Manuel Martínez-Sellés
Jesús Velásquez-Rodríguez
Beta-blockers in acute coronary syndrome patients: The concept of 'gradient of benefit' [0.03%]
急性冠脉综合征患者中的β阻滞剂治疗：“剂量-疗效关系”概念
Fernando Montenegro Sá,João Morais
Fernando Montenegro Sá